Increasing demand for minimally invasive procedures, rise in prevalence of menorrhagia, and rise in awareness regarding endometrial ablation are some key factors expected to drive market growth
According to Emergen Research, the global endometrial ablation devices market size was USD 1,049.9 million in 2020 and is expected to reach USD 1,596.9 million in 2028 and register a revenue CAGR of 5.3% during the forecast period, 2021-2028.
Market Dynamics:
Endometrial ablation is a medical procedure that allows endometrium to be removed from the uterine wall. Endometrium ablation is a treatment that helps to destroy such thin layers of the uterus in order to stop abnormal severe uterine bleeding. This procedure is highly suggested when uterine bleeding is no longer managed by any means of medications. Endometrial ablation uniformly reduces menstrual blood loss, improves menstrual-related and overall quality of life, and reduces the need for hysterectomy in women who undergo the procedure. This has further boosted demand for endometrial ablation devices and is expected to drive market revenue growth over the forecast period.
Increasing incidences of gynecological disorders in females, including menorrhagia which drives patients to seek sophisticated surgical methods like endometrial ablation are some factors expected to positively impact revenue growth of the market over the forecast period. Menorrhagia is one of the most common gynecologic diseases in women, in which menstruation occurs at regular cycle intervals but is accompanied by excessive blood flow for an extended period of time.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/765
According to statistics issued by the World Health Organization (WHO), around 18 million females aged 30 to 55 years experienced heavy menstrual bleeding in 2018. Heavy menstrual bleeding was often treated with hysterectomy but over the recent years endometrial ablation has been widely adopted due to its numerous advantages such as it can be performed in OPD, is painless, and has a faster recovery time. Several devices have been approved for the treatment of the whole endometrial cavity due to their easy usage, increased safety, and enhanced patient outcomes and this is another key factor expected to fuel revenue growth of the market going ahead.
However, increasing concerns associated with faulty designs, manufacturing errors, and inappropriate treatment and management leading to bleeding, pain, or infection can hamper market growth to a certain extent over the forecast period. Endometrial ablation procedures can also lead to puncture or injury to uterine wall or surrounding organs due to improper use of surgical instruments and this can also restrain adoption of endometrial ablation devices and in turn, negatively impact revenue growth of the market.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Radiofrequency Ablation Segment Revenue to Expand at a Rapid CAGR:
Radiofrequency ablation segment is expected to register a rapid revenue CAGR over the forecast period due to its increased effectiveness, convenience, speed of treatment, and minimal risk to patient. Also, the procedure can be repeated if there is a new possibility of new cancer and provide immediate pain relief to patients.
Check Our Prices@ https://www.emergenresearch.com/select-license/765
Clinic Segment to Register Significant Revenue Growth:
Clinic segment is expected to register significant revenue growth over the forecast period owing to advancements in endometrial ablation techniques, availability of advanced technologies that requires minimal space, and increasing government and private focus on development in healthcare infrastructure. In addition, major pharmaceutical companies outsource clinical trials for the treatment of endometrial ablation and this has further streamlined operations and outcomes of clinical trials and is expected to further contribute to revenue growth over the forecast period.
North America to Account for Largest Revenue Share:
North America is expected to account for largest revenue share in the global market over the forecast period due to rapid adoption of advanced technologies such as robotics, machine learning (ML) in surgical procedures, increasing number of clinical trials across the region, and rising investment to implement Artificial Intelligence-based technologies to improve efficiency in healthcare.
Major Companies in the Market Include:
- Boston Scientific Corporation
- Olympus Corporation
- Smith & Nephew plc. (Medtronic plc.)
- Idoman Teoranta, AEGEA Medical, Inc.
- CooperSurgical Inc.
- Richard Wolf GmbH
- Hologic, Inc.
- Johnson & Johnson
- Minerva Surgical, Inc.
For the purpose of this report, Emergen Research has segmented the global endometrial ablation devices market on the basis of technology type, end-use, and region:
Technology Type Outlook (Revenue, USD Million; 2018–2028)
- Cryoablation
- Radiofrequency Ablation
- Hysteroscopic Ablation
- Thermal Balloon
- Hydrothermal Ablation
- Others
End-use Outlook (Revenue, USD Million; 2018–2028)
- Ambulatory Surgery Center
- Hospital
- Clinic
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/endometrial-ablation-devices-market
Regional Outlook (Revenue, USD Million; 2018–2028)
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- France
- K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Turkey
- Rest of MEA
Take a Look at our Related Reports:
Forensic Technology Market By Type (Polymerase Chain Reaction, Capillary Electrophoresis, Next Generation Sequencing, Rapid DNA Analysis, Automated Liquid Handling Technology, Microarrays), By Application (Healthcare, Law Enforcement Agencies, Banking & Financial Institutions, Telecom) and By Regions Forecasts to 2027
3D Printing Healthcare Market By Component, By Technology, By Application, By End-Users, Forecasts to 2027
Population Health Management Solutions Market By Component (Services, Software), By Mode of Deployment (On-Premises, Cloud-Based), By End User (Healthcare Providers, Healthcare Payers, Others), and By Region, Forecasts to 2027
Vaccine Market Size, Share, Trends, By Type (Monovalent Vaccines, Multivalent Vaccines), By Patient Type (Pediatric Patients, Adult Patients), By Technology (Inactivated & Subunit Vaccines, Conjugate Vaccines, Recombinant Vaccines), By Disease, By Route of Administration, and By Region Forecast to 2028
Bionics Market Analysis By Product Type (Ear Bionics, Vision, Orthopedic, Cardiac, Others), By Method of Fixation (External, Implantable), By Region, Forecast to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/press-release/global-endometrial-ablation-devices-market